➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Baxter
Medtronic
Express Scripts
Dow

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc. (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-10-03
Court District Court, D. Delaware Date Terminated 2018-12-11
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Plaintiff Referred To Sherry R. Fallon
Parties WEST-WARD PHARMACEUTICAL CORPORATION
Patents 6,037,157; 7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,297; 8,097,655; 8,415,395; 8,440,722
Attorneys William G. James
Firms Proctor Heyman Enerio LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-10-03 1 A. United States Patent Number 7,964,647 (“the ‘647 Patent”), titled “COLCHICINE COMPOSITIONS… B. United States Patent Number 7,964,648 (“the ‘648 Patent”), titled “METHODS FOR CONCOMITANT… C. United States Patent Number 7,981,938 (“the ‘938 Patent”), titled “COLCHICINE COMPOSITIONS… D. United States Patent Number 8,097,655 (“the ‘655 Patent”), titled “METHODS FOR CONCOMITANT… E. United States Patent Number 8,440,722 (“the ‘722 Patent”), titled “METHODS FOR CONCOMITANT External link to document
2015-09-10 109 A 10/1999 Broder eta!. 6,037,157 A 3/2000 Norbeck eta!. …(57) ABSTRACT 6,037,157 A 3/2000 Norbeck eta!. 6,067,524… 1. This action for patent infringement arises under the patent laws of the United States, … A. United States Patent Number 7,964,647 (“the ’647 Patent”), titled “COLCHICINE COMPOSITIONS… B. United States Patent Number 7,964,648 (“the ’648 Patent”), titled “METHODS FOR CONCOMITANT External link to document
2015-09-22 111 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,619,004, 7,964,647; 7,964,648…2014 12 December 2018 1:14-cv-01268 Patent Plaintiff District Court, D. Delaware External link to document
2014-10-09 21 ;the '655 patent"); 8,440,722 ("the '722 patent"); and 7,964,647 ("the '…;655 patent), ketoconazole ('648 patent), or verapamil ('722 patent). The '938 patent is directed….S. Patent Nos. 7,964,648 ("the '648 patent"); 7,981,938 ("the '938 patent"…#39;647 patent") (collectively, "the asserted patents"). The '655, '648 and '…655, '648, and '722 patents. Based on the listing of these patents in the FDA's Orange Book External link to document
2014-10-14 28 of U.S. Patent Number 7,981,938 and representative claim 1 of U.S. Patent Number 7,964,647. …Exhibit V is a true and correct copy of U.S. Patent Number 7,964,647, entitled COLCHICINE COMPOSITIONS AND …as Exhibit C is a true and correct copy of U.S. Patent Number 7,981,938, entitled COLCHICINE COMPOSITIONS…as Exhibit D is a true and correct copy of U.S. Patent Number 8,097,655, entitled METHODS FOR CONCOMITANT…elements of representative claims 3 and 5 of U.S. Patent Number 8,097,655. External link to document
2014-10-03 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,964,647; US 7,964,648; US…2014 12 December 2018 1:14-cv-01268 Patent Plaintiff District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Moodys
Dow
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.